Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice

N Wagner; MM Lenders; K Kuhl; L Reinhardt; M Fuchss; N Ring; G Richtig; C Ebel; F Andre; R Stager; C Zellweger; SH Sturmer; Roland Lang; M Paar; P Gussek; S Kimeswenger; A Oellinger; T Amaral; A Forschner; U Leiter-Stoppke; B Weide; M Gassenmaier; A Schraag; B Klumpp; W Hoetzenecker; M Ziemer; C Berking; J Mangana; VA Nguyen; P Terheyden; E Richtig; C Loquai; S Diem; A Cozzio; M Rocken; C Garbe; C Gebhardt; F Meier; T Eigentler; L Flatz

Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice

N Wagner
, MM Lenders
, K Kuhl
, L Reinhardt
, M Fuchss
, N Ring
, G Richtig
, C Ebel
, F Andre
, R Stager
, C Zellweger
, SH Sturmer
, Roland Lang
, M Paar
, P Gussek
, S Kimeswenger
, A Oellinger
, T Amaral
, A Forschner
, U Leiter-Stoppke

B Weide, M Gassenmaier, A Schraag, B Klumpp, W Hoetzenecker, M Ziemer, C Berking, J Mangana, VA Nguyen, P Terheyden, E Richtig, C Loquai, S Diem, A Cozzio, M Rocken, C Garbe, C Gebhardt, F Meier, T Eigentler, L Flatz

Department of Dermatology and Allergology

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	3-4
Journal	JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
Volume	20
Publication status	Published - 2022

Cite this

Wagner, N., Lenders, MM., Kuhl, K., Reinhardt, L., Fuchss, M., Ring, N., Richtig, G., Ebel, C., Andre, F., Stager, R., Zellweger, C., Sturmer, SH., Lang, R., Paar, M., Gussek, P., Kimeswenger, S., Oellinger, A., Amaral, T., Forschner, A., ... Flatz, L. (2022). Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 20, 3-4.

@article{12be9def085b4fd2a6d2c6be41af7454,

title = "Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice",

author = "N Wagner and MM Lenders and K Kuhl and L Reinhardt and M Fuchss and N Ring and G Richtig and C Ebel and F Andre and R Stager and C Zellweger and SH Sturmer and Roland Lang and M Paar and P Gussek and S Kimeswenger and A Oellinger and T Amaral and A Forschner and U Leiter-Stoppke and B Weide and M Gassenmaier and A Schraag and B Klumpp and W Hoetzenecker and M Ziemer and C Berking and J Mangana and VA Nguyen and P Terheyden and E Richtig and C Loquai and S Diem and A Cozzio and M Rocken and C Garbe and C Gebhardt and F Meier and T Eigentler and L Flatz",

year = "2022",

language = "English",

volume = "20",

pages = "3--4",

journal = "JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT",

issn = "1610-0379",

publisher = "Wiley Verlag ",

}

Wagner, N, Lenders, MM, Kuhl, K, Reinhardt, L, Fuchss, M, Ring, N, Richtig, G, Ebel, C, Andre, F, Stager, R, Zellweger, C, Sturmer, SH, Lang, R, Paar, M, Gussek, P, Kimeswenger, S, Oellinger, A, Amaral, T, Forschner, A, Leiter-Stoppke, U, Weide, B, Gassenmaier, M, Schraag, A, Klumpp, B, Hoetzenecker, W, Ziemer, M, Berking, C, Mangana, J, Nguyen, VA, Terheyden, P, Richtig, E, Loquai, C, Diem, S, Cozzio, A, Rocken, M, Garbe, C, Gebhardt, C, Meier, F, Eigentler, T & Flatz, L 2022, 'Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice', JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, vol. 20, pp. 3-4.

Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice. / Wagner, N; Lenders, MM; Kuhl, K et al.
In: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 20, 2022, p. 3-4.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice

AU - Wagner, N

AU - Lenders, MM

AU - Kuhl, K

AU - Reinhardt, L

AU - Fuchss, M

AU - Ring, N

AU - Richtig, G

AU - Ebel, C

AU - Andre, F

AU - Stager, R

AU - Zellweger, C

AU - Sturmer, SH

AU - Lang, Roland

AU - Paar, M

AU - Gussek, P

AU - Kimeswenger, S

AU - Oellinger, A

AU - Amaral, T

AU - Forschner, A

AU - Leiter-Stoppke, U

AU - Weide, B

AU - Gassenmaier, M

AU - Schraag, A

AU - Klumpp, B

AU - Hoetzenecker, W

AU - Ziemer, M

AU - Berking, C

AU - Mangana, J

AU - Nguyen, VA

AU - Terheyden, P

AU - Richtig, E

AU - Loquai, C

AU - Diem, S

AU - Cozzio, A

AU - Rocken, M

AU - Garbe, C

AU - Gebhardt, C

AU - Meier, F

AU - Eigentler, T

AU - Flatz, L

PY - 2022

Y1 - 2022

M3 - Abstract (Journal)

SN - 1610-0379

VL - 20

SP - 3

EP - 4

JO - JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

JF - JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

ER -